Italia markets close in 6 hours 48 minutes

Ekso Bionics Holdings, Inc. (0IFR.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
1,5000-1,6310 (-52,09%)
Al 03:28PM GMT. Mercato aperto.
Schermo intero
Chiusura precedente3,1310
Aperto3,0901
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno3,0901 - 3,0901
Intervallo di 52 settimane3,0901 - 3,0901
Volume30
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)1,96
Rapporto PE (ttm)N/D
EPS (ttm)-1,0110
Prossima data utili23 feb 2022 - 28 feb 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Ekso Bionics Reports Third Quarter 2021 Results

    RICHMOND, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended September 30, 2021. Recent Highlights and Accomplishments Reported revenue of $3.0 million in the third quarter of 2021Achieved gross margin of approximately 59% in the third quarter of 2021Booked a total of 16 EksoNR units in the third quarter of 202

  • GlobeNewswire

    Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021

    RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2021 after the close of trading on Tuesday, November 2, 2021. Management will host a conference call beginning at 1:30 p.m. PT, 4:30 p.m. ET to discuss the financial results and recent business developments. A live webcas

  • GlobeNewswire

    Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

    RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investor Conference held on September 13 - 15, 2021. The fireside chat will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Monday, September 13, 2021 throughout the entirety of the conference and on th